Previous close | 33.30 |
Open | N/A |
Bid | 33.50 |
Ask | 38.50 |
Strike | 115.00 |
Expiry date | 2026-01-16 |
Day's range | 33.30 - 33.30 |
Contract range | N/A |
Volume | |
Open interest | N/A |
FDA approves Merck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive and the expanded use of AbbVie's (ABBV) Skyrizi and AstraZeneca's (AZN) Imfinzi.
Some Footsie firms are extremely large, but that doesn't mean they couldn't get even bigger. Here's one such FTSE 100 share I'd buy right now. The post 1 heavyweight FTSE 100 share I’d buy as London retakes its crown appeared first on The Motley Fool UK.
The European Commission approves AstraZeneca's (AZN) Truqap in combination with Faslodex for ER-positive, HER2-negative advanced or metastatic breast cancer.